Community-based values for 2009 pandemic influenza A H1N1 illnesses and vaccination-related adverse events

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Lavelle, Tara A ^a,b   Meltzer, Martin I ^c   Gebremariam, Achamyeleh ^d   Lamarand, Kara ^d   Fiore, Anthony E ^c   Prosser, Lisa A ^d  

^a HARVARD UNIVERSITY   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; FEMALE; GUILLAIN BARRE SYNDROME; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; SCHOOL CHILD; VACCINATION; ADOLESCENT; DEMOGRAPHY; IMMUNOLOGY; INFANT; INFLUENZA; INFLUENZA VIRUS A H1N1; INFORMATION PROCESSING; MIDDLE AGED; PANDEMIC; PATHOGENICITY; REGRESSION ANALYSIS; STATISTICS;

ADOLESCENT; ADULT; AGED; CHILD; DATA COLLECTION; FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PANDEMICS; REGRESSION ANALYSIS; RESIDENCE CHARACTERISTICS; VACCINATION; YOUNG ADULT;

EID: 83655183707     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027777     Document Type: Article

References (25)

1. National Center for Immunization and Respiratory Diseases (2009) Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 58: 1-8.
2. Prosser LA, Bridges CB, Uyeki TM, Rego VH, Ray GT, et al. (2005) Values for preventing influenza-related morbidity and vaccine adverse events in children. Health Qual Life Outcomes 3: 18.
3. Prosser LA, Payne K, Rusinak D, Shi P, Uyeki T, et al. (2011) Valuing health across the lifespan: health state preferences for seasonal influenza illnesses in patients of different ages. Value Health 14: 135-143.
4. Johnston SS, Rousculp MD, Palmer LA, Chu BC, Mahadevia PJ, et al. (2010) Employees' willingness to pay to prevent influenza. Am J Manag Care 16: e205-214.
5. Gold MR, (1996) Cost-effectiveness in health and medicine New York Oxford University Press pp. xxiii 425.
6. Dennis JM, (2010) KnowledgePanel® Design Summary: KNOWLEDGEPANEL® OVERVIEW. Knowledge Networks. [cited 2011 February 8]; Available:http://www.knowledgenetworks.com/knpanel/docs/KnowledgePanel(R)-Design-Summary-Description.pdf.
7. (2009) RESPONDENT INCENTIVES FOR KNOWLEDGEPANEL®. [cited 2011 February 8]; Available:http://www.knowledgenetworks.com/ganp/irbsupport/docs/KN%20IRB%20Doc%20-%20Section%204%20-%20Respondent%20Incentives.doc.
8. Johannesson M, (1996) Theory and methods of economic evaluation of health care Dordrecht; Boston Kluwer pp. x 245.
9. Efron B, (1987) Better Bootstrap Confidence-Intervals. Journal of the American Statistical Association 82: 171-185.
10. Attema AE, Brouwer WB, (2010) The value of correcting values: influence and importance of correcting TTO scores for time preference. Value Health 13: 879-884.
11. Hanley JA, Negassa A, Edwardes MD, Forrester JE, (2003) Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol 157: 364-375.
12. Lin LI, (1989) A concordance correlation coefficient to evaluate reproducibility. Biometrics 45: 255-268.
13. Eisenberg D, Freed GL, (2007) Reassessing how society prioritizes the health of young people. Health Aff (Millwood) 26: 345-354.
14. Eisenberg D, Freed GL, Davis MM, Singer D, Prosser LA, (2011) Valuing health at different ages: evidence from a nationally representative survey in the US. Appl Health Econ Health Policy 9: 149-156.
15. U.S. Department of Health and Human Services USDoHS, editor (2008) Guidance on Allocating and Targeting Pandemic Influenza Vaccine. [cited 2011 March 17]; Available: http://www.flu.gov/individualfamily/vaccination/allocationguidance.pdf.
16. Wittenberg E, Halpern E, Divi N, Prosser LA, Araki SS, et al. (2006) The effect of age, race and gender on preference scores for hypothetical health states. Qual Life Res 15: 645-653.
17. Gaskin DJ, Arbelaez JJ, Brown JR, Petras H, Wagner FA, et al. (2007) Examining racial and ethnic disparities in site of usual source of care. J Natl Med Assoc 99: 22-30.
18. Lillie-Blanton M, Martinez RM, Salganicoff A, (2001) Site of medical care: do racial and ethnic differences persist? Yale J Health Policy Law Ethics 1: 15-32.
19. Weinstein MC, Torrance G, McGuire A, (2009) QALYs: the basics. Value Health 12 (Suppl 1): S5-9.
20. Brazier J, Rowen D, Tsuchiya A, Yang Y, Young TA, (2011) The impact of adding an extra dimension to a preference-based measure. Soc Sci Med 73: 245-253.
21. SteelFisher GK, Blendon RJ, Bekheit MM, Lubell K, (2010) The public's response to the 2009 H1N1 influenza pandemic. N Engl J Med 362: e65.
22. Prosser LA, Kuntz KM, Bar-Or A, Weinstein MC, (2003) Patient and community preferences for treatments and health states in multiple sclerosis. Mult Scler 9: 311-319.
23. Ubel PA, Loewenstein G, Jepson C, (2003) Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Qual Life Res 12: 599-607.
24. Baron J, Asch DA, Fagerlin A, Jepson C, Loewenstein G, et al. (2003) Effect of assessment method on the discrepancy between judgments of health disorders people have and do not have: a web study. Med Decis Making 23: 422-434.
25. van Hoek AJ, Underwood A, Jit M, Miller E, Edmunds WJ, (2011) The Impact of Pandemic Influenza H1N1 on Health-Related Quality of Life: A Prospective Population-Based Study. PLoS One 6: e17030.